Zarzuelo Romero, M.J.; Pérez Ramírez, C.; Carrasco Campos, M.I.; Sánchez Martín, A.; Calleja Hernández, M.Á.; Ramírez Tortosa, M.C.; Jiménez Morales, A.
Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. J. Pers. Med. 2021, 11, 335.
https://doi.org/10.3390/jpm11050335
AMA Style
Zarzuelo Romero MJ, Pérez Ramírez C, Carrasco Campos MI, Sánchez Martín A, Calleja Hernández MÁ, Ramírez Tortosa MC, Jiménez Morales A.
Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. Journal of Personalized Medicine. 2021; 11(5):335.
https://doi.org/10.3390/jpm11050335
Chicago/Turabian Style
Zarzuelo Romero, María José, Cristina Pérez Ramírez, María Isabel Carrasco Campos, Almudena Sánchez Martín, Miguel Ángel Calleja Hernández, María Carmen Ramírez Tortosa, and Alberto Jiménez Morales.
2021. "Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis" Journal of Personalized Medicine 11, no. 5: 335.
https://doi.org/10.3390/jpm11050335
APA Style
Zarzuelo Romero, M. J., Pérez Ramírez, C., Carrasco Campos, M. I., Sánchez Martín, A., Calleja Hernández, M. Á., Ramírez Tortosa, M. C., & Jiménez Morales, A.
(2021). Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. Journal of Personalized Medicine, 11(5), 335.
https://doi.org/10.3390/jpm11050335
